Venere, M <br/><br/>
Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.  [electronic resource] 

 -  Cell death and differentiation  Feb 2014 
 - 258-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5403 
<br/><br/><label>Standard No.: </label>10.1038/cdd.2013.136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>DNA Damage<br/>DNA Repair<br/>Dose-Response Relationship, Drug<br/>Glioblastoma--metabolism<br/>Humans<br/>Male<br/>Mice<br/>Mice, Nude<br/>Neoplastic Stem Cells--drug effects<br/>Phenotype<br/>Phthalazines--pharmacology<br/>Piperazines--pharmacology<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Reactive Oxygen Species--metabolism<br/>Structure-Activity Relationship